Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: A multicentre cohort study
The Lancet Infectious Diseases Feb 02, 2018
Hermans HE, et al. - For low-income and middle-income countries, WHO guidelines define failure of Antiretroviral therapy (ART) with a lenient threshold of viraemia (HIV RNA viral load ≥1000 copies per mL). In a large South African cohort, researchers examined the occurrence of detectable viraemia during ART below this threshold and its effect on treatment outcomes. Findings revealed a frequent occurrence of low-level viraemia in this cohort. This increased the risk of virological failure and switch to second-line ART. To meet UNAIDS-defined targets aimed at halting the global HIV epidemic, strategies for management of low-level viraemia need to be incorporated into WHO guidelines.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries